UTMD — Utah Medical Products Share Price
0.000.00%
Last trade - 00:00- $174.23m
- $90.91m
- $40.90m
- 95
- 67
- 38
- 74
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 1.52 | ||
| Price to Tang. Book | 1.77 | ||
| Price to Free Cashflow | 12.26 | ||
| Price to Sales | 4.38 | ||
| EV to EBITDA | 5.86 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 11.44% | ||
| Return on Equity | 11.29% | ||
| Operating Margin | 33.23% | ||
Financial Summary
| Year End 31st Dec | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $m | 42.18 | 49.05 | 52.28 | 50.22 | 40.9 | n/a | n/a | -2.7% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | -22.12 | +34.29 | +15.41 | +6.07 | -9.83 | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Utah Medical Products, Inc. develops, manufactures and markets a broad range of disposable and reusable specialty medical devices. The Company has a particular interest in healthcare for women and their babies. The Company’s broad range of products includes those used in critical care areas and the labor and delivery departments of hospitals, as well as outpatient clinics and physicians’ offices. Its products include BT-CATH, CVX-RIPE, AROM-COT, MUC-X, CORDGUARD, DISPOSA-HOOD, DELTRAN PLUS, GESCO, PICC-NATE, LETZ System, Filshie Clip System, PATHFINDER PLUS, SUPRAPUBIC CATHETERIZATION, LIBERTY System, ENDOCURETTE, LUMIN, and BioPharm HP-PRT, among others. BT-CATH is a patented uterine balloon tamponade catheter for controlling severe postpartum hemorrhage. MUC-X is an aspiration device. The Company produces medical devices for blood pressure monitoring and blood management, electrosurgery, labor and delivery, neonatal intensive care, urological care and women’s pelvic health.
Directors
- Kevin Cornwell CHM (74)
- Brian Koopman CFO
- Ernst Hoyer LED (83)
- Paul Richins DRC (60)
- James Beeson IND (79)
- Barbara Payne IND (74)
- Last Annual
- December 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- April 21st, 1978
- Public Since
- December 1st, 1982
- No. of Shareholders
- 2,000
- No. of Employees
- 155
- Sector
- Healthcare Equipment & Supplies
- Industry
- Healthcare
- Exchange
- NASDAQ Global Select Market
- Shares in Issue
- 3,248,210
- Address
- 7043 S 300 West, MIDVALE, 84047
- Web
- http://www.utahmed.com
- Phone
- +1 8015661200
- Auditors
- Haynie & Co.
Upcoming Events for UTMD
Q2 2025 Utah Medical Products Inc Earnings Release
Q3 2025 Utah Medical Products Inc Earnings Release
Similar to UTMD
10X Genomics
NASDAQ Global Select Market
Accuray
NASDAQ Global Select Market
Akoya Biosciences
NASDAQ Global Select Market
Align Technology
NASDAQ Global Select Market
Alphatec Holdings
NASDAQ Global Select Market
FAQ
What is the Utah Medical Products share price?
As of Today at 23:54 UTC, shares in Utah Medical Products are trading at $55.10. This share price information is delayed by 15 minutes.
How has the Utah Medical Products share price performed this year?
Shares in Utah Medical Products last closed at $55.10 and the price had moved by -21.79% over the past 365 days. In terms of relative price strength the Utah Medical Products share price has underperformed the S&P500 Index by -30.39% over the past year.
What are the analyst and broker recommendations for Utah Medical Products?
There is no consensus recommendation for this security.
Find out moreWhat is the Utah Medical Products dividend yield?
The Utah Medical Products dividend yield is 2.2% based on the trailing twelve month period.
Does Utah Medical Products pay a dividend?
Last year, Utah Medical Products paid a total dividend of $1.21, and it currently has a trailing dividend yield of 2.2%.Looking ahead, shares in Utah Medical Products are due to go ex-dividend on 2025-06-16 and the next dividend pay date is 2025-07-03.
When does Utah Medical Products next pay dividends?
Utah Medical Products are due to go ex-dividend on 2025-06-16 and the next dividend pay date is 2025-07-03. The historic dividend yield on Utah Medical Products shares is currently 2.2%.
How do I buy Utah Medical Products shares?
To buy shares in Utah Medical Products you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Utah Medical Products?
As of the previous close price of $55.10, shares in Utah Medical Products had a market capitalisation of $178.98m.
Where are Utah Medical Products shares listed?
Here are the trading details for Utah Medical Products:
- Country of listing: United States
- Exchange: NSQ
- Ticker Symbol: UTMD
What kind of share is Utah Medical Products?
Based on an overall assessment of its quality, value and momentum Utah Medical Products is currently classified as a Contrarian. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Utah Medical Products share price forecast for 2025?
We could not find analyst target price data for this security.
Find out moreWhat is the trend in the Utah Medical Products share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Utah Medical Products. Over the past six months, its share price has underperformed the S&P500 Index by -17.49%.
As of the last closing price of $55.10, shares in Utah Medical Products were trading -11.03% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Utah Medical Products PE Ratio?
The Utah Medical Products PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at $55.10.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Utah Medical Products?
Utah Medical Products' management team is headed by:
- Kevin Cornwell - CHM
- Brian Koopman - CFO
- Ernst Hoyer - LED
- Paul Richins - DRC
- James Beeson - IND
- Barbara Payne - IND